• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 20
    • Directory
    • Microsites
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 20
  • Directory
  • Microsites
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    Newsmakers: Darren Shirley

    Are You Prepared for the 2023 DSCSA Deadline?

    Rethinking the Changing Role of the CRO

    23rd Annual Salary Survey

    Pharma 4.0 and the Modernizing Power of Digital Technology Transfer
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    Takeda to Expand U.S. Footprint

    Croda Pharma's Lipid Systems Capability to Support mRNA Vaccines

    WuXi STA Opens High-Potency API Plant

    Catalent Expands Primary Packaging Capabilities at its Shiga, Japan Facility

    Phastar Appoints Chris Schoonmaker as Chief Operations Officer
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    Takeda to Expand U.S. Footprint

    Croda Pharma's Lipid Systems Capability to Support mRNA Vaccines

    WuXi STA Opens High-Potency API Plant

    Catalent Expands Primary Packaging Capabilities at its Shiga, Japan Facility

    Shimadzu Scientific Instruments Extends HQ Campus
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    Tubular Glass Primary Packaging for Pharmaceutical, Biotech and Diagnostic Containment

    How to Improve the Cold Chain System in Remote Locations

    Sentry Biopharma Services: Protecting Pharmaceutical Integrity

    Yourway to Build New Flagship European Depot

    Newsmakers: Darren Shirley
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    Takeda to Expand U.S. Footprint

    Croda Pharma's Lipid Systems Capability to Support mRNA Vaccines

    Charles River Labs Opens Plasmid DNA CoE in Cheshire, UK

    EQT Private Equity Acquires SPT Labtech from Battery Ventures

    Ixaka & Minaris Sign Tech Transfer & GMP Manufacturing Agreement for Cell Therapy Candidate
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    Should Remote Pharma GMP Audits End After COVID?

    Why is Big Pharma Increasingly Adopting 505(b)(2)?

    Sentry Biopharma Services: Protecting Pharmaceutical Integrity

    Selkirk Pharma Appoints New Head of Quality

    Be Safer by Doing Less: The Future of Zero Touch AE Case Processing
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    IDT Biologika

    Vector Partners Limited

    Quotient Sciences

    Aphena Pharma Solutions

    Qosina
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    IDT Biologika

    Vector Partners Limited

    Quotient Sciences

    Aphena Pharma Solutions

    Qosina
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • White Papers
    • Podcasts
    • Infographics
    • Supplier Microsite
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Conference Sessions
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Columns

    The Future of Pharma

    Robert Califf’s appointment to head of FDA is a signal of the future of pharma.

    The Future of Pharma
    Ben Locwin, Contributing Editor02.01.22
    As winter gets into full swing in the Northern Hemisphere, Robert Califf is at the beginning of his appointment as Commissioner of The US Food and Drug Administration (FDA). This will bring with it substantial changes in 2022 (and 2023) not only within the FDA’s internal functioning, but broadly across the pharma and medtech industries.

    There is a relatively obscure conjecture in business operations called “Conway’s Law.” It suggests that when organizations construct communication hierarchies, these hierarchies resemble a recursive self-similar arrangement as that of the larger organization itself. In essence, like Russian Nesting Dolls (matruyeshka), each layer down of an organization makes mini organizations that resemble and communicate like the layer above.

    The interesting connection here is that when companies change their leadership, this often catalyzes wholesale changes to these structures. This, then, is often impetus to enact brand new changes to how work is done, or reinvigorate changes that may have been latent. This happens with varying degrees of shocking predictability. So, what will Robert Califf’s appointment change at the FDA? And why does it matter? There are two major reasons:
    1. Leadership will change the organization.
    2. What the FDA does—and finds important—will make the industry fall in line to follow suit.
    The Leadership Derivative
    If leadership will change an organization, it must be in a certain way. I can express this in the form:

    dL/dt > 0

    Meaning, simply, that changes in leadership change organizations over time. What we know to be true is that, in my conjectural equation above: Changing leadership with respect to time leads to non-zero outcomes. Or, perhaps more precisely:

    0 > dL/dt > 0

    Changing leadership with respect to time leads to a non-zero outcome that can be either positive or negative. But in either case, the company won’t stay exactly static.

    We often can’t know the outcome unless we look in retrospect after the new leadership experiment has had a chance to run its course. So, whether Robert Califf’s appointment will be a success or otherwise has a lot to do with providence, chance-y situations, and many other things outside of his control (not least of which are lobbyists, budgetary constraints, activists, and so on). But we can focus on element #2 from our list above: Planning for industry’s change in the forecasted direction(s) of the FDA’s changes.

    Where the Head Goes, The Body Follows
    You may find that this glib quote is worth a look-up. However, Google will tell you that it comes from Ryan Holiday (2014) in the form, “Where the head goes, the body follows. Perception precedes action. Right action follows the right perspective.” Unfortunately for Mr. Holiday, the framework for this quote originated much earlier and from the far divergent discipline of Judo.

    In any case, on the chessboard of regulatory approvals, ‘the head’ in the aphorism above refers to the United States’ Regulatory agency, the FDA. ‘The body’ refers to our industry, which endeavors to garner approval for their investigational medicinal therapeutics. When shifts occur within the FDA—and other global agencies as well, including MHRA, EMA, ICH documents, etc.—they reverberate through the industry and catalyze changes in how work is done.

    Probably the most voluminous changes in the industry seen in some time due to a regulatory change were those associated with updates in ICH E6 revision 2. Literal years of change went on within the pharma industry to prepare for the second revision of that document and its associated modifications. Changes in the FDA will come in-part from Califf’s interests and directions toward which he finds it important for the agency to go. And where these directions point, so too will the industry follow.

    Forward-Looking Themes At FDA
    So, what are these likely changes, then? Well, if I deconstruct what I know of Robert Califf and his messaging internally and externally, they begin with data, and end with data.

    First, changes to ‘how’ we measure data in the industry.

    Then, using data to determine the changes that were made to data handling were, in fact, robust and effective.

    Think of it as an FDA internal CAPA to improve data handling, along with necessary Effectiveness Checks.

    Past performance is a fairly mediocre predictor of future behavior. But it’s a predictor nonetheless. So, if we look to some of the things that Califf spearheaded in his last run leading the FDA (as its 22nd Commissioner in 2016-2017), we can get a sense of the directionality of the future, within some margin of error. To that end, he had launched IMEDS in 2017, which allowed drug companies to mine patient safety data to identify potential problems with their drugs. IMEDS lists the following benefits on their website:
    • Access to large volume of patient data
    • Reliability of an established network
    • Direct experience and expertise leveraging FDA’s Sentinel Common Data Model and tools
    • Accessing and contributing to collective knowledge building around real-world evidence generation

    Califf also, in 2016, wrote an article with his colleague NIH Director Francis Collins, wherein he laid out a plan to create a “learning health system that takes full advantage of digital data to help us make informed choices.” So, what I do know of his past performance and interests is that he is deeply interested in the philosophy of transforming how our industry collects and uses data.

    He also has been interested in toughening stances on tobacco as well as opioids, including having opioid manufacturers present different types of data showing risk-to-benefit value of their therapies and longer-term safety data. This is part of a rebalanced approach to reviewing opioid drug submissions to look differently at the benefits and risks.

    So, while Califf’s plans for modernizing the way Sponsors and the FDA collect and use patient data were largely shelved in 2017 when he left his office, this is the most evidence-based place to go for understanding what he’ll focus on principally when he hits his stride in his renewed position. The FDA is also working internally on the rollout and establishment of its DMAP (Data Modernization Action Plan) and continuation of its TMAP (Technology Modernization Action Plan), which will be guaranteed to have direct and indirect impacts on the industry. So, prepare accordingly. As is always the case: Chance favors the prepared. 

    References
    • Regan-Udall Foundation of the FDA. (2021). https://reaganudall.org/programs/imeds
    • Califf, R. et al. (2016). Transforming Evidence Generation to Support Health and Health Care Decisions. The New England Journal of Medicine, 375. 2395-2400.



    Doing science right: Contributing editor Ben Locwin with Neil deGrasse Tyson
    Ben Locwin is a healthcare industry executive, has been appointed to many boards and committees, and frequently works at the moving frontier of the industry, where the future transitions to the present. He has advised investors, developed new therapies and clinical approaches, and has worked to increase public access to healthcare. He has been featured in Forbes, The Wall Street Journal, USA Today, and other top-tier media.

    Related Content

      Loading, Please Wait..
      Trending
      • Vetter’s Newest Clinical Manufacturing Site Completes First Customer Fills
      • Almac Participates In Global Clinical Supply BlockChain Working Group
      • Regulatory Report: Analytical Procedure Development
      • Shimadzu Scientific Instruments Extends HQ Campus
      • Batavia Enters Commercial Manufacturing Business
      Breaking News
      • Takeda to Expand U.S. Footprint
      • Croda Pharma's Lipid Systems Capability to Support mRNA Vaccines
      • WuXi STA Opens High-Potency API Plant
      • Catalent Expands Primary Packaging Capabilities at its Shiga, Japan Facility
      • Phastar Appoints Chris Schoonmaker as Chief Operations Officer
      View Breaking News >
      CURRENT ISSUE

      June 2022

      • Newsmakers: Darren Shirley
      • Are You Prepared for the 2023 DSCSA Deadline?
      • Rethinking the Changing Role of the CRO
      • 23rd Annual Salary Survey
      • Pharma 4.0 and the Modernizing Power of Digital Technology Transfer
      • CEO Spotlight: David Chang
      • Changes are on the Horizon for Single-use Systems in Pharmaceutical Manufacturing
      • CRO Industry Market Report

      Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
      You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

      • About Us
      • Privacy Policy
      • Terms And Conditions
      • Contact Us

      follow us

      Subscribe
      Nutraceuticals World

      Latest Breaking News From Nutraceuticals World

      Pharmavite Expands in Ohio with $200 Million Investment
      Nestlé Health Science Expands in New Zealand with Deal to Buy The Better Health Company
      Younger Consumers Drive Growing Demand for Ingestible Beauty and Skin Care Products
      Coatings World

      Latest Breaking News From Coatings World

      Clariant’s Launches Dispersogen Flex 100
      Lincoln Tech Enters Partnership with AkzoNobel
      AkzoNobel Launches International Interzone 945GF
      Medical Product Outsourcing

      Latest Breaking News From Medical Product Outsourcing

      ENDRA Life Sciences Issued 27th Patent
      AI-Enabled SKOUT Device Improves Colorectal Cancer Screening
      Simon Johnson Appointed as Senior Business Development VP at MedAcuity
      Contract Pharma

      Latest Breaking News From Contract Pharma

      Takeda to Expand U.S. Footprint
      Croda Pharma's Lipid Systems Capability to Support mRNA Vaccines
      WuXi STA Opens High-Potency API Plant
      Beauty Packaging

      Latest Breaking News From Beauty Packaging

      Latest Updates About Cosmoprof North America
      Meet the Clean Beauty Brand for Dogs
      Paco Rabanne Introduces Elle Fanning as Ambassador for New ‘Fame’ Fragrance
      Happi

      Latest Breaking News From Happi

      Two-Part Skincare Product Patented by Estée Lauder Companies
      American Cleaning Institute Pens Letter to Congress Encouraging Examination of Recyclability Improvements
      The Expert Panel for Fragrance Safety Celebrates 55 Years
      Ink World

      Latest Breaking News From Ink World

      INX Launches INXFlex Contour for Shrink Sleeve Market
      Xerox Announces Unexpected Passing of Vice Chairman and CEO John Visentin
      MNYPIA Golf Outing Set to Tee Off on Aug. 17
      Label & Narrow Web

      Latest Breaking News From Label & Narrow Web

      Meyers purchased by third generation of Dillon family
      Epson now shipping ColorWorks C4000 inkjet label printer
      Nobelus launches new films for prime labels
      Nonwovens Industry

      Latest Breaking News From Nonwovens Industry

      What You’re Reading on Nonwovens-Industry.com
      Daio, Livedo Partner to Recycle Diapers
      Suominen Launches Hydraspun Reserve
      Orthopedic Design & Technology

      Latest Breaking News From Orthopedic Design & Technology

      3D Systems and EMS-GRILTECH Enter Strategic Partnership
      AIP Researchers Develop Microfluidic-Based Soft Robotic Prosthetic
      David Sharp Named Global Marketing VP at Catalyst OrthoScience
      Printed Electronics Now

      Latest Breaking News From Printed Electronics Now

      Impinj Launches E910 RFID Reader Chip for Next Generation Enterprise IoT
      onsemi Receives Recognition for Sustainability for Third Straight Year
      Xerox Announces the Unexpected Passing of Vice Chairman and CEO John Visentin

      Copyright © 2022 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

      AD BLOCKER DETECTED

      Our website is made possible by displaying online advertisements to our visitors.
      Please consider supporting us by disabling your ad blocker.


      FREE SUBSCRIPTION Already a subscriber? Login